| Human brain glioblastoma cells do not induce but do respond to the bleomycin-induced bystander response from lung adenocarcinoma cells SAS Basheerudeen, C Mani, MAK Kulkarni, K Pillai, A Rajan, ... Mutation Research/Genetic Toxicology and Environmental Mutagenesis 757 (2 …, 2013 | 23 | 2013 |
| Expression and purification of polioviral proteins in E. coli, and production of antisera as reagents for immunological assays M Uma, PP Rao, K Nagalekshmi, NR Hegde Protein expression and purification 128, 115-122, 2016 | 8 | 2016 |
| A novel point mutation (L70P) inactivates poliovirus 3C protease. M Uma, SR Hegde, PP Rao, K Nagalekshmi, S Gauthami, D Kumar, ... Acta virologica 62 (1), 68-77, 2018 | 4 | 2018 |
| Immunogenicity of a Candidate Ebola Hemorrhagic Fever Vaccine in Mice Based on Controlled In Vitro Expression of Ebolavirus Glycoprotein D Kumar, S Gauthami, M Uma, K Nagalekshmi, PP Rao, A Basu, KM Ella, ... Viral Immunology 31 (7), 500-512, 2018 | 2 | 2018 |
| IFIH1 (MDA5) is required for innate immune detection of intron-containing RNA expressed from the HIV-1 provirus MH Guney, K Nagalekshmi, SM McCauley, C Carbone, O Aydemir, ... bioRxiv, 2023 | | 2023 |
| Deciphering the molecular basis of the global emergence of Non-Tuberculous Mycobacteria as important human respiratory pathogens K Nagalekshmi Queen's University Belfast, 2021 | | 2021 |
| An image-based screening system for the study of Mycobacterium avium persistence and drug discovery K Nagalekshmi, C O’Kane, G Schroeder Access Microbiology 2 (7A), 802, 2020 | | 2020 |
| Parameters of controlled expression of potentially toxic recombinant proteins in E. coli with picornaviral 3ABC as a model M Uma, S Mallavarapu, K Nagalekshmi, PP Rao, NR Hegde Indian Journal of Comparative Microbiology, Immunology and Infectious …, 2016 | | 2016 |
